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Endoscopic third ventriculostomy has no
higher costs than ventriculoperitoneal shunt
Terceiro ventriculostomia endoscópica não apresenta custos mais elevados do que a
derivação ventrículo peritoneal
Benicio Oton de Lima1, Riccardo Pratesi2
ABSTRACT
Objective: To evaluate the cost of endoscopic third ventriculostomy (ETV) compared to ventriculoperitoneal shunt (VPS) in the treatment of
hydrocephalus in children. Method: We studied 103 children with hydrocephalus, 52 of which were treated with ETV and 51 with VPS in a
prospective cohort. Treatment costs were compared within the first year after surgery, including subsequent surgery or hospitalization.
Results: Twenty (38.4%) of the 52 children treated with VPS needed another procedure due to shunt failure, compared to 11 (21.5%) of
51 children in the ETV group. The average costs per patient in the group treated with ETV was USD$ 2,177,66±517.73 compared to
USD$ 2,890.68±2,835.02 for the VPS group. Conclusions: In this series there was no significant difference in costs between the ETV and
VPS groups.
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RESUMO
Objetivo: Avaliar os custos da terceiro ventriculostomia endoscópica (TVE) comparada à derivação ventrículo peritoneal (DVP) no
tratamento da hidrocefalia em crianças. Método: Foram estudadas 103 crianças com hidrocefalia, 52 das quais tratadas com TVE e 51
com DVP numa coorte prospectiva. Foram comparados os custos do tratamento no primeiro ano após a cirurgia, incluindo cirurgias ou
internações subsequentes. Resultados: Vinte (38,4%) das 52 crianças tratadas com DVP necessitaram de outro procedimento por
disfunção da válvula, em comparação a 11 (21,5%) das 51 crianças do grupo tratado com TVE. Os custos médios por paciente no grupo
tratado com TVE foram de USD$ 2,177.66±517.73 comparados a USD$ 2.890,68±2.835,02 para o grupo DVP. Conclusões: Nesta série não
houve diferença significativa de custos entre o grupo TVE e DVP.
Palavras-chave: hidrocefalia, derivação ventriculoperitoneal, neuroendoscopia, análise de custos.
Endoscopic third ventriculostomy (ETV) and ventriculo-
peritoneal shunt (VPS) insertion are the most used forms
of treatment of obstructive hydrocephalus in children and
adults1,2,3. Although there are many papers addressing the
choice of the method of treatment of hydrocephalus4,5, there
is no consensus6,7,8,9. The risk of ETV failure usually becomes
gradually lower compared with the risk of VPS failure with
increasing time from the surgery. Almost half of the shunt
procedures performed in a hospital are shunt revisions10.
The effectiveness of ETV shows a success rate extremely vari-
able, from 30-90%11,12. If there is no significant difference in the
outcome between the two techniques of treatment of hydro-
cephalus, the cost becomes an important concern, because no
society has unlimited resources, and this is particularly
important in the developing world13. The objective of our
study was to compare the costs and outcome of treatment
of obstructive hydrocephalus with ETV compared to VPS dur-
ing the first year after surgery in a Brazilian Public Hospital.
METHOD
Study Design
A prospective cohort study of children who underwent
initial hydrocephalus surgical treatment at the Hospital de
Base do Distrito Federal (HBDF) during the years 2007 and
2008 was conducted. The children were observed during
one year after the surgery. The study was approved by the
Committee of Ethics and Research of the Secretary of
Health of the Federal District (no. 026/07).
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During the time of the study, 162 children were admitted
for the treatment of hydrocephalus. There were different
etiologies of hydrocephalus, and the choice of treatment
(ETV or VPS) was at the discretion of the neurosurgeon
on call. Children with severe neurological malformations
such as hydranencephaly were not included. In cases with
specific etiologies of hydrocephalus, such as that associated
with myelomeningocele, post-infectious and post hemorrha-
gic, the indication of treatment was almost always VPS.
These cases were also excluded from the study.
The cohort studied consisted of 103 children, 52 treated
with VPS and 51 treated with ETV. Information recorded
included age, sex, etiology of hydrocephalus, imaging, sur-
gery (ETV or VPS) and operative complications, length of
hospital stay after the surgery, late complications, hospitali-
zations for failures of VPS or ETV up to one year after the
first surgery, total number of in-patient hospital days due
to failure, number of new surgeries needed for correction
of the initial failure, follow up during one year after the first
surgery, head circumference at surgery and after one year,
improvement in neurological status after one year, and total
costs paid by the Brazilian Government. Cases of early fail-
ure of the procedure were counted as a new admission even
when occurred during the first week after surgery.
The ETV was conducted using a rigid endoscope14
inserted in the lateral ventricle (usually from the right) free
hand. The floor of the third ventricle was perforated using
a 4 French balloon catheter, midway between the mammil-
lary bodies and the infundibular recess in the midline, and
was considered successful if the Liliequist membrane was
opened, and the surgeon could see the basilar tip or its
branches. The VPS were performed with the use of a fixed
pressure valve available at the moment of the surgery
(Ventura Biomédica, Sao José do Rio Preto, Brazil, or
Phoenix Biomedical, PA, USA).
The number of hospital days was counted after the first
surgery for hydrocephalus. The failure of the procedure (ETV
or VPS) was defined by any subsequent surgery for cere-
brospinal fluid (CSF) diversion15 or death related do hydro-
cephalus. The head circumference was considered by
percentile, according to the child’s age. The neurological sta-
tus was evaluated using the Denver Scale adapted for chil-
dren up to 7 years of age. For those older than 7 years the
Health Utilities Index16 was used. The children were exam-
ined prior to surgery and at one-year follow up and the
exams compared.
The costs of the treatment of the children with hydro-
cephalus in our series were calculated taking into account
the values reimbursed by the Brazilian government. The
Brazilian Health Care System pays for the health care for
all Brazilian citizens. Most of the people who seek treatment
in Public Hospitals in Brasilia are low-income, and do not
have a private health insurance. The Unified Health
System of the Brazilian Government pays a total amount
of $ 1,760.89 (all monetary units are given in US dollars for
the year 2008) for each patient treated with ETV. In this
amount is included all the hospitalization expenses for a per-
iod of up to 6 days. The payment is made by the procedure
per patient, so that hospitals try to optimize their costs,
reducing hospitalization time, and trying to avoid complica-
tions. For those treated with VPS, the amount of $ 833.73 is
paid for the surgery and hospital costs, and an extra $ 469.88
is paid for the shunt valve and catheters. In this study, the
costs were calculated for each patient according to the pro-
cedure, imaging tests, hospital stay, and complications. If the
child needed a new surgery for treatment of VPS or ETV fail-
ure, the costs of this treatment were added.
Data were analyzed using SPSS Advanced Statistics 20.0
(SPSS Inc., Chicago, IL, USA).
RESULTS
The group was composed of 77 (47.5%) girls and 85
(52.5%) boys. There were different etiologies of hydroceph-
alus (Table 1). The cohort study group was composed of
103 hydrocephalic children with a mean age of 24.6±25.2
months, 52 of them treated with VPS (mean age 17.6±18.3
months) and 51 treated with ETV (mean age 32.4±29.5
months). The mean postoperative hospital stay was 2.1±0.8
days, ranging from 1-4 days, and was similar for both groups
(ETV 2.24±0.6 days and VPS 2.06±0.8 days).
From the 52 treated with VPS, 20 (38%) showed failure,
and it was necessary to perform 61 new operations, ranging
from 1 to 10 new surgeries per child. From the 51 treated
with ETV, 11 (21.5%) showed failure, and were reoperated
10 times. One child with cerebrospinal fluid (CSF) leak was
managed conservatively. The causes of failure of the first
surgical treatment for hydrocephalus are listed on Table 2.
Some complications did not need surgical correction,
such as positional deformities in the skull due to CSF over
drainage in nine children treated with VPS, none was
observed in those treated with ETV. In two children in the
Table 1. Etiologies of hydrocephalus and surgery.
Etiology VPS ETV Total
Neurocysticercosis 0 1 1
Post traumatic 3 2 5
Post infectious 8 1 9
Dandy Walker Malformation 8 1 9
Posterior fossa tumor 4 6 10
Post hemorrhagic 16 0 16
Myelomeningocele 23 1 24
Congenital obstructive 45 43 88
Total 107 55 162
VPS: ventricle peritoneal shunt; ETV: endoscopic third ventriculostomy.
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VPS group was noted temporary accumulation of CSF in the
valve path, but as there was good control of the hydroceph-
alus, they were treated conservatively. In the ETV group, one
child had transient hemiparesis and another had acute
hydrocephalus almost 10 months after the procedure and
died. The average head circumference of the children in
the VPS group was in the percentile 93.8±15.7 and in the
ETV group was 91.1±12.4. The head circumference one year
after the first surgery was in the 50.7±41.2 percentile in the
VPS group and 76.9±17.6 percentile in the ETV group. No dif-
ference in neurological status improvement was noted
between the VPS and ETV group.
The survival rate of the CSF diversion at one year, shown
in Figure, was 78.4±5.8% for ETV and 61.5±6.7% for VPS.
Despite the trend toward greater survival time of ETV com-
pared to VPS, there is no statistical significance by the Log
Rank and Breslow tests of equality of survival distributions.
The average costs paid for the treatment of hydroceph-
alus during the period of study was $ 2,537.60±2,068.43
ranging from $ 1,357.75 to $ 12,923.15. The average
cost for treatment of hydrocephalus with VPS was
$ 2,890.69±2,835.02 and for those treated with ETV was
$ 2,177.60±517.73. There is no statistically significant
difference between the two groups, but in the present series
there is a trend to lower costs in the ETV group.
DISCUSSION
Pediatric hydrocephalus places a substantial burden on
patients and the health care system. Since the introduction
of ETV in the 1990s, this technique has rapidly gained new
enthusiasts and was indicated as the procedure of choice
in the treatment of obstructive hydrocephalus17,18,19, avoiding
the fear of VPS malfunction and need for further surgery.
Probably a child with a shunt malfunction generates more
emergency visits, creates more anxiety in parents and physi-
cians, and consumes more resources than all other pediatric
neurosurgery problems20,21. The choice between VPS and
ETV should take into account the clinical outcomes and
the expenditures for each surgical procedure22.
As described before in previous studies8, we did not
observe difference in outcome in children with hydroceph-
alus treated with ETV or VPS. There was no difference in
postoperative hospital stay between the two groups, and
both procedures were well tolerated by children. The num-
ber of reoperations was higher in the VPS group, and two
children have been submitted to 10 new surgical procedures.
Considering the emotional burden for the child and for par-
ents for every surgery, it is thought that the emotional suffer-
ing is greater in this group than with ETV, which required a
smaller number of reoperations23,24,25,26. In our study CSF
infection was observed only in the VPS group. Whereas ven-
triculitis may impair cognitive function of children26, this is a
factor that must be taken into consideration when choosing
between ETV and VPS in the initial treatment of obstructive
hydrocephalus. The VPS led to a faster control of large head
circumference, but otherwise caused an increased frequency
of positional deformities in the skull. This data needs to be
further studied by comparing groups of infants treated with
ETV and VPS. Since there is a tendency to treat older chil-
dren with ETV, it is possible that this issue will be not ade-
quately answered. A complication found only in the group
treated with ETV was transient neurological deficit and late
death. This is a rare complication and there is report of only
few cases in the world27. We observed a continuous decrease
in the Kaplan-Meier survival curve for the patients treated
with VPS in the first year of follow up. In the ETV group
there was a rapid decrease after the procedure followed by
a more constant curve.
This is the first Brazilian study of the economic costs
associated with hydrocephalus. Comparing the costs of
ETV with VPS in a public hospital, we noted a tendency
to higher costs in the VPS group with passing of time,
although this difference was not statistically significant,
as have been related before22. When dealing with costs for
chronic childhood illness like hydrocephalus, it should
be noted that there are transportation costs, access to
services, and usually there is a decrease in the family
income23. The stress and worry caused by short monetary
Table 2. Causes of failure of treatment.
VPS ETV
CSF fistula 1 1
Infection 7 0
Obstruction 12 10
VPS: ventricle peritoneal shunt; ETV: endoscopic third ventriculostomy.
Figure. Kaplan Meier curve for ETV or VPS. ETV survival curve is
shown in dotted line and VPS survival curve in continuous line.
VPS: ventricle peritoneal shunt; ETV: endoscopic third ven-
triculostomy.
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resources may have effects on the well being of the
whole family25.
The initial costs of the treatment of hydrocephalus paid
by public money were higher in the ETV group than in
the VPS group. However, when comparing costs with one
year follow up, the final costs are reversed, with more costly
treatment with VPS than with ETV. It should be noted that
this series shows a tendency, but the numbers are not stat-
istically significant.
In this series, the choice of the surgical technique for the
treatment of obstructive hydrocephalus could not be deter-
mined by the clinical results, since these results were similar.
Thus the financial aspect becomes important and there was
a tendency after one year of the surgery to lower expenses
when the hydrocephalus was treated with ETV, although
without statistical significance. This trend suggests that
Public Resources should continue to be used in the endo-
scopic treatment of hydrocephalus.
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